Douglas K. Bratton, 10% Owner at Juno Therapeutics, Inc. (JUNO), sold 40,000 shares at $54.75 ($2.2M) on 2015-07-02, disclosed to the SEC on 2015-07-02.
Open-market sale of $2.2M JUNO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| DNLI | BUY | 2017-12-14 | $5.0M | — | Filing → |
| JUNO | SELL | 2015-06-25 | $13.8M | — | Filing → |
| JUNO | BUY | 2014-12-24 | $15.0M | — | Filing → |